(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff
FDA approves lifitegrast for dry eye disease
The FDA has approved Xiidra for the treatment of signs and symptoms of dry eye disease in adults, Shire announced in a press release. Twice-daily Xiidra (lifitegrast ophthalmic solution 5%) is the first prescription eye drop solution indicated for the …
Video Released: Dr. Melissa Hunfalvay presents at TEDxFoggyBottom on how to Think Next about eye-tracking technology
WASHINGTON–(BUSINESS WIRE)–#RightEye–Footage released of RightEye Chief Science Officer Dr. Melissa Hunfalvay speaking at TEDxFoggyBottom earlier this year on the health benefits of eye tracking technology tests and therapies.
Scientists Regrow Severed Nerves in Mice, Restore Vision
Visual stimulation with growth-promoting gene therapy helped retinal neurons regrow and restored some vision after injury, a study showed. It has ‘tremendous’ clinical implications, authors said. Medscape Medical News
Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients
Shire plc announces that the U.S. Food and Drug Administration has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.
Two dosing levels of ranibizumab show good effects in eyes with DME
Two dosing levels of ranibizumab improved visual acuity and decreased central foveal thickness in patients with clinically significant diabetic macular edema, a study found.The prospective study included 46 eyes of 46 patients with DME secondary to dia…